ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Immunization Advocacy Podcast For Global Vaccine Policy Leaders Launched

The Global Health Advocacy Incubator has launched a bilingual podcast aimed at strengthening vaccine policy strategies as countries shift from donor-backed to domestically funded immunization programs.

-- Low- and middle-income countries are under increasing pressure to secure sustainable domestic financing as donor support for immunization programs declines. In response, the Global Health Advocacy Incubator (GHAI) has introduced "One Shot, Long Life!"—a podcast series designed to spotlight policy solutions and frontline advocacy during this pivotal transition.

Additional details are available at https://www.advocacyincubator.org/one-shot-long-life

The podcast's launch comes amid a significant shift in global immunization financing. In 2024, countries supported by Gavi contributed a record $255 million toward their own vaccination programs—an increase of 19% from the previous year. Between 2026 and 2030, these nations are projected to fund nearly $4 billion of program costs, accounting for almost half of total expenditures.

Despite progress, challenges persist. An estimated 14.5 million children remain unvaccinated globally, with nearly 60% residing in 10 countries, including Afghanistan, Nigeria, and India. Outbreaks of vaccine-preventable diseases have surged by 43% since 2021, highlighting the urgent need for stronger policy advocacy and financial commitment.

"Countries are taking greater ownership of their immunization programs at a time when global vaccine coverage has not fully recovered from the pandemic," a GHAI representative stated. "This podcast brings forward the voices of advocates working to ensure sustainable financing reaches every child who needs protection."

The podcast series targets vaccine policy stakeholders across Africa and Asia, offering insights through interviews with advocates, policymakers, and public health experts. Featured episodes look at strategies to close Nigeria's $200 million annual immunization funding gap and examine the role of legislators in mobilizing domestic resources. Each installment shares real-world tactics to address policy bottlenecks and improve equitable vaccine access.

Episodes are released in both English and French and are available on major platforms.

About Global Health Advocacy Incubator

The Global Health Advocacy Incubator partners with local civil society, governments, and stakeholders to advance public health through policy change. Over the past decade, it has supported legislative victories affecting more than four billion people in 32 countries. Its areas of focus include immunization, maternal and reproductive health, and primary health care. GHAI is supported by Gavi, the Vaccine Alliance, and is headquartered in Washington, D.C.

For more information, visit https://www.advocacyincubator.org/program-areas/health-systems-strengthening

Contact Info:
Name: Jen Patterson
Email: Send Email
Organization: Global Health Advocacy Incubator
Address: 1400 I Street Northwest Suite 1200, Washington, DC 20005, United States
Website: https://www.advocacyincubator.org/

Source: PressCable

Release ID: 89169412

In the event of any inaccuracies, problems, or queries arising from the content shared in this press release, we encourage you to notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team will be readily available to respond and take swift action within 8 hours to rectify any identified issues or assist with removal requests. Ensuring the provision of high-quality and precise information is paramount to us.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.